<DOC>
	<DOC>NCT00097357</DOC>
	<brief_summary>The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment will also be studied.</brief_summary>
	<brief_title>BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Undergoing elective unilateral total knee replacement surgery. Willing and able to undergo bilateral ascending contrast venography. Able to inject (by self or caregiver) study medication subcutaneously. Women of childbearing potential. Women who are pregnant or breastfeeding. Under some conditions, subjects weighing more than 300 lbs. (136kg) and/or Body Mass Index (BMI) &gt;=35 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Prevention of deep vein thrombosis and pulmonary embolism</keyword>
	<keyword>Preventive therapy</keyword>
</DOC>